In this study, we showed that caffeine can directly bind to G6PDH with high affinity and compete with NADP+ for G6PDH binding, which inhibits G6PDH activity, disrupts redox homeostasis, and leads to suppression of RCC proliferation, both in vitro and in vivo. Here, H6PD is linked to renal cell carcinoma.